110 related articles for article (PubMed ID: 8737151)
1. In-vitro activity of psychiatric drugs against Corynebacterium urealyticum (Corynebacterium group D2).
Muñoz-Bellido JL; Muñoz-Criado S; García-Rodríguez JA
J Antimicrob Chemother; 1996 May; 37(5):1005-9. PubMed ID: 8737151
[TBL] [Abstract][Full Text] [Related]
2. In vitro susceptibility of Corynebacterium group D2 and Corynebacterium jeikeium to twelve antibiotics.
Philippon A; Bimet F
Eur J Clin Microbiol Infect Dis; 1990 Dec; 9(12):892-5. PubMed ID: 2073900
[TBL] [Abstract][Full Text] [Related]
3. Synergistic activity between vancomycin or teicoplanin and gentamicin or tobramycin against pathogenic diphtheroids.
Spitzer PG; Eliopoulos GM; Karchmer AW; Moellering RC
Antimicrob Agents Chemother; 1988 Apr; 32(4):434-7. PubMed ID: 2967670
[TBL] [Abstract][Full Text] [Related]
4. Drug interaction potential of fluoxetine, sertraline, and paroxetine in four state psychiatric hospital populations.
Markowitz JS; Devine CL
Ther Drug Monit; 1997 Apr; 19(2):244-5. PubMed ID: 9108660
[No Abstract] [Full Text] [Related]
5. In vitro activity of ciprofloxacin, moxifloxacin, vancomycin and erythromycin against planktonic and biofilm forms of Corynebacterium urealyticum.
Soriano F; Huelves L; Naves P; Rodríguez-Cerrato V; del Prado G; Ruiz V; Ponte C
J Antimicrob Chemother; 2009 Feb; 63(2):353-6. PubMed ID: 19056748
[TBL] [Abstract][Full Text] [Related]
6. Unorthodox antibiotic combinations including ciprofloxacin against high-level gentamicin resistant enterococci.
Tripodi MF; Utili R; Rambaldi A; Locatelli A; Rosario P; Florio A; Ruggiero G
J Antimicrob Chemother; 1996 Apr; 37(4):727-36. PubMed ID: 8722538
[TBL] [Abstract][Full Text] [Related]
7. In vitro susceptibility of Streptococcus pneumoniae strains to nine beta-lactam antibiotics and the killing kinetics of cephalosporins alone and in combination with vancomycin or gentamicin.
Marton A; Major P
Microb Drug Resist; 1996; 2(3):361-9. PubMed ID: 9158796
[TBL] [Abstract][Full Text] [Related]
8. Antimicrobial susceptibility pattern of Corynebacterium striatum.
Martínez-Martínez L; Pascual A; Bernard K; Suárez AI
Antimicrob Agents Chemother; 1996 Nov; 40(11):2671-2. PubMed ID: 8913489
[TBL] [Abstract][Full Text] [Related]
9. [Corynebacterium group D2. Clinical study, biochemical identification and antibiotic sensitivity].
Marty N; Clave D; Cancet B; Henry-Ferry S; Didier J
Pathol Biol (Paris); 1988 May; 36(5):460-4. PubMed ID: 3136426
[TBL] [Abstract][Full Text] [Related]
10. [Antibiotic susceptibility analysis of Enterococcus spp. isolated from urine].
Rudy M; Nowakowska M; Wiechuła B; Zientara M; Radosz-Komoniewska H
Przegl Lek; 2004; 61(5):473-6. PubMed ID: 15515808
[TBL] [Abstract][Full Text] [Related]
11. In vitro activity of 79 antimicrobial agents against Corynebacterium group D2.
García-Rodriguez JA; García Sánchez JE; Muñoz Bellido JL; Nebreda Mayoral T; García Sánchez E; García García I
Antimicrob Agents Chemother; 1991 Oct; 35(10):2140-3. PubMed ID: 1759839
[TBL] [Abstract][Full Text] [Related]
12. Activity of nine antimicrobial agents against Corynebacterium group D2 strains isolated from clinical specimens and skin.
Fernández-Roblas R; Prieto S; Santamaría M; Ponte C; Soriano F
Antimicrob Agents Chemother; 1987 May; 31(5):821-2. PubMed ID: 3606082
[TBL] [Abstract][Full Text] [Related]
13. In vitro bactericidal activity of the glycopeptide compounds vancomycin, teicoplanin and ramoplanin (A-16686/MDL 62,198).
O'Hare MD; Felmingham D; Grüneberg RN
J Chemother; 1989 Jul; 1(4 Suppl):210-1. PubMed ID: 16312373
[No Abstract] [Full Text] [Related]
14. Antimicrobial susceptibility of Corynebacterium group D2.
Santamaría M; Ponte C; Wilhelmi I; Soriano F
Antimicrob Agents Chemother; 1985 Dec; 28(6):845-6. PubMed ID: 4083869
[TBL] [Abstract][Full Text] [Related]
15. [Susceptibility of Corynebacteria isolated in St Petersburg to antibacterial drugs].
Gladin DP; Kozlova NS; Zaitseva TK; Zveriakina NN; Khval' SA
Antibiot Khimioter; 1997; 42(12):16-8. PubMed ID: 9480648
[TBL] [Abstract][Full Text] [Related]
16. Synergy study of vancomycin or teicoplanin plus gentamicin against enterococci, Staphylococcus aureus and coagulase-negative staphylococci by time-kill method.
Thamlikitkul V
J Med Assoc Thai; 1991 Dec; 74(12):669-74. PubMed ID: 1839906
[TBL] [Abstract][Full Text] [Related]
17. Antimicrobial susceptibilities of Corynebacterium species and other non-spore-forming gram-positive bacilli to 18 antimicrobial agents.
Soriano F; Zapardiel J; Nieto E
Antimicrob Agents Chemother; 1995 Jan; 39(1):208-14. PubMed ID: 7695308
[TBL] [Abstract][Full Text] [Related]
18. [Sensitivity of methicillin resistant staphylococci to linezolid and some other antimicrobial agents].
Ertek M; Yazgi H; Aktaş E; Ayyildiz A; Parlak M
Mikrobiyol Bul; 2003 Oct; 37(4):235-40. PubMed ID: 14748259
[TBL] [Abstract][Full Text] [Related]
19. Activities of gemifloxacin and five other antimicrobial agents against Listeria monocytogenes and coryneform bacteria isolated from clinical samples.
Martínez-Martínez L; Joyanes P; Suárez AI; Perea EJ
Antimicrob Agents Chemother; 2001 Aug; 45(8):2390-2. PubMed ID: 11451706
[TBL] [Abstract][Full Text] [Related]
20. [Bactericidal activity of combinations of ticarcillin-clavulanic acid or other beta-lactams (amoxicillin, piperacillin-tazobactam, ticarcillin) with gentamicin against Enterococcus faecalis and E. faecium].
Leclercq R; Duval J
Pathol Biol (Paris); 1995 Apr; 43(4):245-52. PubMed ID: 7567109
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
